Source: Annual Congress 2009 - Inflammatory cells and cytokines
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Sorokina, V. Mineev, M. Nyoma, V. Trofimov (Saint-Petersburg, Russian Federation). New aspects of the action of IL-4 on the activity of the transcription factor STAT6 in allergic and non-allergic asthma. Eur Respir J 2009; 34: Suppl. 53, 2152

Member's Comments

No comment yet.

Related content which might interest you: New aspects of the IL-4-receptor alpha-chain lymphocyte expression in allergic and non-allergic asthma Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 Transcription factor GATA-3 as a specific marker of allergic bronchial asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 TNFAIP3/A20 expression in allergic asthma Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 GATA-3 or T-bet: Who is the crucial marker of allergic bronchial asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Analysis of cytokine signaling through the STAT6 activation in patients with atopic steroid-free asthma Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007 The role of transcription factor PAX-5 (BSAP) in asthma severity and in the activity of allergic inflammation Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Improvement of allergic asthma symptoms by targeting STAT6 with siRNA Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017 Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020 Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Antisense-ECE RNA inhibited dust mite-induced IL-5 release from PBMCs of patients with allergic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 546s Year: 2003 The role of mast cells in allergic, non-allergic and aspirin-induced asthma and rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 589s Year: 2005 The role of IL-13, IL-4Rα cytokine gene variants in atopic and non-atopic asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Does allergens influence resistin levels in children with allergic rhinitis? Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 The level of cytokines in allergic rhinitis at the height of the disease Source: Eur Respir J 2007; 30: Suppl. 51, 369s Year: 2007 Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010